Entry Detail



General Information

Database ID:exR0089573
RNA Name:hsa-miR-195-5p
RNA Type:miRNA
Chromosome:chr17
Starnd:-
Coordinate:
Start Site(bp):7017667End Site(bp):7017687
External Links:hsa-miR-195-5p



Disease Information

Disease Name:Preterm Birth
Disease Category:Urogenital Diseases and Pregnancy Complications
MeSH ID:D047928
Type:Diseases Category/Female Urogenital Diseases and Pregnancy Complications
Alias:Premature Birth//Birth, Premature//Births, Premature//Premature Births//Preterm Birth//Birth, Preterm//Births, Preterm//Preterm Births



Expression Detail

GEO ID:GSE106224
Description:Exosomal RNA may reflect placenta deficiencies and provide better biomarker in preterm birth
Experimental Design:Disease vs Control
Case Disease Type:Preterm Birth
Case Disease SubType:NA
Case Sample:Preterm Birth
Control Sample:Control
Number of Case:20
Number of Control:50
Number of Samples:70





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ABHD2
chr15
89087459
89202355
+
AMER1
chrX
64185117
64205708
-
ANKRD17
chr4
73073376
73258798
-
ARHGAP35
chr19
46860997
47005077
+
ASB1
chr2
238426742
238452250
+
BACE1
chr11
117285207
117316259
-
BIRC5
chr17
78214186
78225636
+
CA12
chr15
63321378
63381846
-
CYB561A3
chr11
61348745
61362299
-
DCAF7
chr17
63550477
63594279
+
ERG28
chr14
75649791
75660876
-
FGFR1
chr8
38400215
38468834
-
FLOT2
chr17
28879335
28897733
-
FSD1
chr19
4304598
4323843
+
KDSR
chr18
63327726
63367228
-
MAPK1IP1L
chr14
55051647
55070194
+
MRPS2
chr9
135499984
135504673
+
MYB
chr6
135181308
135219173
+
PARM1
chr4
74933095
75050115
+
PDE4A
chr19
10416773
10469630
+
PLPP6
chr9
4662294
4665258
+
SCAMP4
chr19
1905372
1926013
+
STEAP3
chr2
119223831
119265652
+
TOB2
chr22
41433494
41446801
-
TSPYL2
chrX
53082367
53088540
+
ZBTB34
chr9
126860665
126885878
+
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000540
chr14
55799534
55821940
+
hsa_circ_0001005
chr2
53921020
53978078
-
hsa_circ_0001723
chr7
91924202
91948826
+
hsa_circ_0000458
chr12
124071293
124074996
+
hsa_circ_0001699
chr7
40027197
40041630
+
hsa_circ_0001387
chr4
1902352
1936989
+
hsa_circ_0001168
chr20
47691321
47707559
+
hsa_circ_0000552
chr14
71880664
71948928
+
hsa_circ_0000038
chr1
28800065
28802803
+
hsa_circ_0000652
chr15
90984737
90986710
+
hsa_circ_0001472
chr5
36953719
36976504
+
hsa_circ_0001263
chr3
5215701
5216099
+
hsa_circ_0000799
chr17
65941524
65972074
+
hsa_circ_0001164
chr20
45891031
45923523
-
hsa_circ_0000032
chr1
25666964
25669564
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
MIR29B2CHG
chr1
207801518
207879115
-
LINC00662
chr19
27681072
27794005
-
AC002470.2
chr22
20979462
20998121
+
NUTM2A-AS1
chr10
87201647
87342612
-
SNHG1
chr11
62851984
62855953
-
AC114980.1
chr5
93860669
93863825
-
LINC01184
chr5
127939152
128083172
-
SNHG25
chr17
64145970
64146476
+
NEAT1
chr11
65422774
65445540
+
AC021092.1
chr19
44103007
44113183
-
AL391244.1
chr1
1420245
1422691
+
SNHG12
chr1
28578538
28583132
-
LINC02035
chr3
122886941
122892416
+
AP000317.2
chr21
34073592
34360033
+
NUTM2B-AS1
chr10
79661394
79826594
-
MZF1-AS1
chr19
58559129
58574797
+
MCM3AP-AS1
chr21
46229196
46259390
+
XIST
chrX
73820649
73852723
-
AL359924.1
chr1
237862175
237928321
+
AC020978.7
chr16
68224713
68227734
+
AC021078.1
chr5
149494314
149504670
-
AC003092.1
chr7
94022833
94066661
+
SNHG16
chr17
76557764
76565348
+
FGD5-AS1
chr3
14920347
14948424
-
HCG18
chr6
30286690
30327382
-
MIR503HG
chrX
134543119
134546642
-
LINC00649
chr21
33915534
33977691
+
AC079781.5
chr7
97851688
97972985
-
STAG3L5P-PVRIG2P-PILRB
chr7
100336104
100367831
+
AL031282.2
chr1
1702736
1737688
-
Display:



Experiment Detail

GEO ID:GSE106224
Sample Source:Blood
Source Fraction:Plasma
Platform:GPL18573
Method:NGS
Num of detected RNA Type:1
Num of detected RNAs of this Type:1522
Sample treatment protocol:Whole blood samples were centrifuged for 15 minutes at 2,000×g at 4°C to get plasma. EVs were isolated from 100 ul of plasma using size exclusion columns (iZON qEV, Cambridge MA) with de-gassed 1X PBS from a total of 22 selected samples, 11 from each group (Table 1). Eluate (~500 ul for each fraction) was collected in microfuge tubes individually. The protein contains and concentration for each fraction were assessed by protein gel electrophoresis and Bradford assay (BioRad, Hercules, CA).
RNA Extract protocol:RNA was isolated from all plasma samples, the 22 EV samples, and 22 corresponding EV-depleted fractions using miRNeasy Micro Kit (Qiagne, Germantown MD).
RNA library preparation protocol:Small RNA sequencing libraries were generated with a modified small RNAseq protocol (manuscript in preparation) that alleviates most of the adapter-miRNA ligation sequence bias problem.



Reference

PMID:29516617
Title:Extracellular vesicle RNAs reflect placenta dysfunction and are a biomarker source for preterm labour
Author:Fallen S, Baxter D, Wu X, Kim TK, Shynlova O, Lee MY, Scherler K, Lye S, Hood L, Wang K
Journal:J Cell Mol Med. 2018 May;22(5):2760-2773.
Description:We have used an improved small RNA library construction protocol and a newly developed size exclusion chromatography (SEC)-based EV purification method to gain a comprehensive view of circulating RNA in plasma and its distribution by analysing RNAs in whole plasma and EV-associated and EV-depleted plasma.